EDGAR Filing Documents for 0001127602-23-019171

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001127602-23-019171

Filing Date

2023-06-21

Accepted

2023-06-21 17:07:25

Documents

Period of Report

2023-06-16

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	form4.html	4
1	PRIMARY DOCUMENT	form4.xml	4	6685
	Complete submission text file	0001127602-23-019171.txt		8315

Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210

Business Address

Type: 4 | Act: 34 | File No.: 001-40097 | Film No.: 231030735

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210

Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362

Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)